Viewing Company
Company Name:
Anthera Pharmaceuticals Inc
CIK:
1316175
Phone:
None
Fiscal Year End:
None
Entity Type:
SIC:
-
Category Type:
Entity Name:
None
First Filing Date:
2011-08-12
Last Filing Date:
2018-05-15
SEC Filings
| Start | End | Frame | Filed | ACCN | Value | View |
|---|---|---|---|---|---|---|
| 2012-07-01 | 2012-09-30 | CY2011Q3 | 2012-11-08 | 0001214659-12-004959 | $ 69,630,637 | View |
| 2013-01-01 | 2013-03-31 | CY2012Q1 | 2013-05-13 | 0001214659-13-002660 | $ 124,124,006 | View |
| 2013-04-01 | 2013-06-30 | CY2012Q2 | 2013-08-06 | 0001214659-13-004383 | $ 19,059,130 | View |
| 2013-07-01 | 2013-09-30 | CY2012Q3 | 2013-11-14 | 0001214659-13-006503 | $ 19,196,140 | View |
| 2012-04-01 | 2012-06-30 | CY2011Q2 | 2012-08-09 | 0001104659-12-056249 | $ 41,098,849 | View |
| 2012-01-01 | 2012-12-31 | CY2012 | 2013-03-26 | 0001214659-13-001633 | $ 57,804,589 | View |
| 2014-01-01 | 2014-12-31 | CY2012 | 2015-03-16 | 0001214659-15-002302 | $ 21,776,269 | View |
| 2015-01-01 | 2015-12-31 | CY2013 | 2016-03-14 | 0001214659-16-010295 | $ 35,631,237 | View |
| 2016-01-01 | 2016-12-31 | CY2014 | 2017-03-16 | 0001214659-17-002018 | $ 41,310,269 | View |
| 2017-01-01 | 2017-12-31 | CY2017 | 2018-03-05 | 0001214659-18-001789 | $ 10,278,391 | View |
| 2014-01-01 | 2014-03-31 | CY2013Q1 | 2014-05-14 | 0001214659-14-003584 | $ 20,123,252 | View |
| 2014-04-01 | 2014-06-30 | CY2013Q2 | 2014-08-14 | 0001214659-14-005908 | $ 21,479,386 | View |
| 2014-07-01 | 2014-09-30 | CY2013Q3 | 2014-11-14 | 0001214659-14-007763 | $ 22,747,308 | View |
| 2015-01-01 | 2015-03-31 | CY2014Q1 | 2015-05-11 | 0001214659-15-003828 | $ 27,595,081 | View |
| 2015-04-01 | 2015-06-30 | CY2014Q2 | 2015-08-10 | 0001214659-15-005948 | $ 35,817,794 | View |
| 2015-07-01 | 2015-09-30 | CY2014Q3 | 2015-11-09 | 0001214659-15-007627 | $ 39,241,738 | View |
| 2016-01-01 | 2016-03-31 | CY2015Q1 | 2016-05-10 | 0001214659-16-011383 | $ 40,049,895 | View |
| 2016-04-01 | 2016-06-30 | CY2015Q2 | 2016-08-09 | 0001214659-16-013059 | $ 41,032,544 | View |
| 2016-07-01 | 2016-09-30 | CY2015Q3 | 2016-11-07 | 0001214659-16-014425 | $ 41,682,669 | View |
| 2017-01-01 | 2017-03-31 | CY2016Q1 | 2017-05-10 | 0001214659-17-003209 | $ 6,759,567 | View |
| 2017-04-01 | 2017-06-30 | CY2017Q2 | 2017-08-09 | 0001214659-17-004902 | $ 10,136,326 | View |
| 2017-07-01 | 2017-09-30 | CY2017Q3 | 2017-11-08 | 0001214659-17-006541 | $ 10,947,338 | View |
| 2018-01-01 | 2018-03-31 | CY2018Q1 | 2018-05-15 | 0001214659-18-003764 | $ 22,166,869 | View |
| 2011-04-01 | 2011-06-30 | CY2011Q2 | 2011-08-12 | 0001104659-11-046569 | $ 34,900,225 | View |
| 2011-07-01 | 2011-09-30 | CY2011Q3 | 2011-11-08 | 0001104659-11-062216 | $ 40,833,495 | View |
| 2011-01-01 | 2011-12-31 | CY2010 | 2012-03-14 | 0001047469-12-002644 | $ 37,417,775 | View |
| 2012-01-01 | 2012-03-31 | CY2012Q1 | 2012-05-04 | 0001104659-12-033177 | $ 41,000,421 | View |
| 2013-01-01 | 2013-12-31 | CY2011 | 2014-03-28 | 0001214659-14-002323 | $ 18,267,413 | View |
SEC Facts By Type
| Type | Name | Description | View |
|---|---|---|---|
| us-gaap | Sales Revenue, Services, Other (Deprecated 2018-01-31) | Amount before allowances and discounts of service revenue classified as other. | View |
| us-gaap | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge. | View |
| us-gaap | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. | View |
| us-gaap | Amortization of Debt Discount (Premium) | Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. | View |
| us-gaap | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. | View |
| us-gaap | Cash, Cash Equivalents, and Short-term Investments | Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable. | View |
| us-gaap | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. | View |
| us-gaap | Earnings Per Share, Basic and Diluted | The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | View |
| us-gaap | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit). | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits. | View |
| us-gaap | Effect of Exchange Rate on Cash and Cash Equivalents | Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies. | View |
| us-gaap | Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations | The effect of exchange rate changes on cash balances in continuing operations held in foreign currencies. | View |
| us-gaap | Excess Tax Benefit from Share-based Compensation, Operating Activities | Amount of cash outflow for realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes. | View |
| us-gaap | Investment Owned, at Fair Value | Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities. | View |
| us-gaap | License and Services Revenue (Deprecated 2018-01-31) | Revenue from multiple-deliverable arrangements that include licensing fees and services revenue. Licensing revenue is consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity. Services revenue may be derived by providing other, nonspecified, services during the reporting period. | View |
| us-gaap | Licenses Revenue (Deprecated 2018-01-31) | Revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity. | View |
| us-gaap | Long-Term Debt, Maturity, Year One | Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Long-Term Debt, Maturity, Year Four | Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Long-Term Debt, Maturity, Year Three | Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Long-Term Debt, Maturity, Year Two | Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. | View |
| us-gaap | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | View |
| us-gaap | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. | View |
| us-gaap | Other Significant Noncash Transaction, Value of Consideration Given | "The value of the noncash (or part noncash) consideration given (for example, liability, equity) in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period." | View |
| us-gaap | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. | View |
| us-gaap | Proceeds from Sale of Property, Plant, and Equipment | The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. | View |
| us-gaap | Proceeds from Sale of Short-term Investments | The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term. | View |
| us-gaap | Research and Development Expense | The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. | View |
| us-gaap | Share-based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period, Weighted Average Grant Date Fair Value (Deprecated 2012-01-31) | The weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect during the reporting period as a result of the occurrence of a terminating event specified in the contractual agreement of the plan. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. | View |
| us-gaap | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | Weighted average price at which option holders acquired shares when converting their stock options into shares. | View |
| us-gaap | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. | View |
| us-gaap | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. | View |
| us-gaap | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. | View |
| us-gaap | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable | The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent | Purchase price of common stock expressed as a percentage of its fair value. | View |
| us-gaap | Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price | Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding. | View |
| us-gaap | Share Price | Price of a single share of a number of saleable stocks of a company. | View |
| us-gaap | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation | Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement. | View |
| us-gaap | Short-term Investments | Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current. | View |
| us-gaap | Square Footage of Real Estate Property (Deprecated 2012-01-31) | The amount of square footage related to a real estate property. | View |
| us-gaap | Stockholders' Equity Attributable to Parent | Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. | View |
| us-gaap | Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments | The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components. | View |
| us-gaap | Weighted Average Number of Shares Issued, Basic | This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic). | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | View |
| us-gaap | Due to Related Parties | Carrying amount as of the balance sheet date of obligations due all related parties. | View |
| dei | Entity Common Stock, Shares Outstanding | Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. | View |
| dei | Entity Public Float | The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. | View |
| us-gaap | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. | View |
| us-gaap | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services. | View |
| us-gaap | Adjustment of Warrants Granted for Services | Adjustment for noncash service expenses paid for by granting of warrants. | View |
| us-gaap | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation | Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement. | View |
| us-gaap | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature | Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature. | View |
| us-gaap | Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings | Amount of decrease in additional paid in capital (APIC) resulting from dividends legally declared (or paid) in excess of retained earnings balance. | View |
| us-gaap | APIC, Share-based Payment Arrangement, Recognition and Exercise | Amount of increase (decrease) to additional paid-in capital (APIC) for recognition and exercise of award under share-based payment arrangement. | View |
| us-gaap | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. | View |
| us-gaap | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration. | View |
| us-gaap | Adjustments to Additional Paid in Capital, Warrant Issued | Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. | View |
| us-gaap | Share-based Payment Arrangement, Expense | Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. | View |
| us-gaap | Amortization of Debt Issuance Costs | Amount of amortization expense attributable to debt issuance costs. | View |
| us-gaap | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. | View |
| us-gaap | Area of Real Estate Property | Area of a real estate property. | View |
| us-gaap | Assets | Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. | View |
| us-gaap | Assets, Current | Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. | View |
| us-gaap | Auction Market Preferred Securities, Stock Series, Shares Authorized | The number of shares of a preferred security the entity has authorized through an auction process. | View |
| us-gaap | Cash and Cash Equivalents, Period Increase (Decrease) | Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. | View |
| us-gaap | Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) | Exercise price per share or per unit of warrants or rights outstanding. | View |
| us-gaap | Class of Warrant or Right, Exercise Price of Warrants or Rights | Exercise price per share or per unit of warrants or rights outstanding. | View |
| us-gaap | Class of Warrant or Right, Number of Securities Called by Each Warrant or Right | Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares. | View |
| us-gaap | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. | View |
| us-gaap | Class of Warrant or Right, Outstanding | Number of warrants or rights outstanding. | View |
| us-gaap | Common Stock, Capital Shares Reserved for Future Issuance | Aggregate number of common shares reserved for future issuance. | View |
| us-gaap | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | View |
| us-gaap | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | View |
| us-gaap | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | View |
| us-gaap | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | View |
| us-gaap | Proceeds from Issuance or Sale of Equity | The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. | View |
| us-gaap | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. | View |
| us-gaap | Current Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations. | View |
| us-gaap | Current State and Local Tax Expense (Benefit) | Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations. | View |
| us-gaap | Debt Conversion, Converted Instrument, Amount | "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." | View |
| us-gaap | Debt Conversion, Original Debt, Amount | "The amount of the original debt being converted in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." | View |
| us-gaap | Debt Instrument, Interest Rate, Stated Percentage | Contractual interest rate for funds borrowed, under the debt agreement. | View |
| us-gaap | Debt Instrument, Unamortized Discount | Amount, after accumulated amortization, of debt discount. | View |
| us-gaap | Debt Issuance Cost (Deprecated 2016-01-31) | Amount of debt issuance costs (for example, but not limited to, legal, accounting, broker, and regulatory fees). | View |
| us-gaap | Deferred Federal Income Tax Expense (Benefit) | Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations. | View |
| us-gaap | Deferred Income Tax Expense (Benefit) | Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. | View |
| us-gaap | Deferred Revenue, Current | Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current. | View |
| us-gaap | Deferred Revenue, Noncurrent | Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent. | View |
| us-gaap | Deferred State and Local Income Tax Expense (Benefit) | Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations. | View |
| us-gaap | Deferred Tax Assets, Goodwill and Intangible Assets | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill. | View |
| us-gaap | Deferred Tax Assets, Gross | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. | View |
| us-gaap | Deferred Tax Assets, Operating Loss Carryforwards | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. | View |
| us-gaap | Deferred Tax Assets, Other | Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other. | View |
| us-gaap | Deferred Tax Assets, Tax Credit Carryforwards | Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards. | View |
| us-gaap | Deferred Tax Assets, Tax Credit Carryforwards, Research | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. | View |
| us-gaap | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Bonuses | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee bonuses. | View |
| us-gaap | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. | View |
| us-gaap | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities. | View |
| us-gaap | Deferred Tax Assets, Valuation Allowance | Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. | View |
| us-gaap | Defined Benefit Plan, Plan Assets, Contributions by Employer | Amount of contribution received by defined benefit plan from employer which increases plan assets. | View |
| us-gaap | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. | View |
| us-gaap | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | Cumulative net losses reported during the development stage. | View |
| us-gaap | Dividends, Preferred Stock | Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK). | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Percent | Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | Percentage of domestic federal statutory tax rate applicable to pretax income (loss). | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Deduction, Dividend, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for dividend. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. | View |
| us-gaap | Employee-related Liabilities, Current | Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | Amount of cost not yet recognized for nonvested award under share-based payment arrangement. | View |
| us-gaap | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | Amount of cost to be recognized for option under share-based payment arrangement. | View |
| us-gaap | Equity Issuance, Amount Per Share (Deprecated 2012-01-31) | The amount per share assigned to the consideration received for equity securities issued by a development stage enterprise during a specific stock issuance since its inception. | View |
| us-gaap | Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) | Amount per share or per unit assigned to the consideration received of equity securities issued for development stage entities. | View |
| us-gaap | Equity Method Investment, Aggregate Cost | This element represents the aggregate cost of investments accounted for under the equity method of accounting. | View |
| us-gaap | Fair Value Adjustment of Warrants | Amount of expense (income) related to adjustment to fair value of warrant liability. | View |
| us-gaap | Fair Value Inputs, Discount Rate (Deprecated 2018-01-31) | Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure fair value. For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt. | View |
| us-gaap | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) | Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. | View |
| us-gaap | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases | Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. | View |
| us-gaap | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. | View |
| us-gaap | Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss) | Amount of unrealized gain (loss) recognized in income for derivative asset (liability) after deduction of derivative liability (asset), measured at fair value using unobservable input (level 3) and still held. | View |
| us-gaap | Gain (Loss) on Sale of Investments | The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities. | View |
| us-gaap | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. | View |
| us-gaap | Income (Loss) from Continuing Operations before Income Taxes, Domestic | The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations. | View |
| us-gaap | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. | View |
| us-gaap | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. | View |
| us-gaap | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. | View |
| us-gaap | Increase (Decrease) in Deferred Revenue | Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable. | View |
| us-gaap | Increase (Decrease) in Employee Related Liabilities | The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. | View |
| us-gaap | Increase (Decrease) in Operating Assets | The increase (decrease) during the reporting period in the aggregate amount of assets used to generate operating income. | View |
| us-gaap | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. | View |
| us-gaap | Increase (Decrease) in Restricted Cash | The net cash inflow or outflow for the increase (decrease) associated with funds that are not available for withdrawal or use (such as funds held in escrow) and are associated with underlying transactions that are classified as investing activities. | View |
| us-gaap | Interest and Other Income | The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business). | View |
| us-gaap | Interest Expense | Amount of the cost of borrowed funds accounted for as interest expense. | View |
| us-gaap | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities. | View |
| us-gaap | Investment Income, Net, Amortization of Discount and Premium | Amount of accretion (amortization) of purchase discount (premium) on nonoperating securities. | View |
| us-gaap | Investment Owned, at Cost | Cost of the investment. | View |
| us-gaap | Proceeds from Other Equity | Amount of cash inflow from the issuance of equity classified as other. | View |
| us-gaap | Investment Owned, Unrecognized Unrealized Appreciation (Depreciation), Net | This element represents the net excess or deficiency of the fair value of an investment (security, contract) over or under its cost (face amount, notional amount), respectively, which excess value or deficiency has not been recognized in earnings of the entity. | View |
| us-gaap | Issuance of Stock and Warrants for Services or Claims | Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims. | View |
| us-gaap | Operating Leases, Rent Expense | Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line. | View |
| us-gaap | Liabilities | Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. | View |
| us-gaap | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. | View |
| us-gaap | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. | View |
| us-gaap | Long-term Debt | Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations. | View |
| us-gaap | Notes Payable, Noncurrent | Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. | View |
| us-gaap | Net Cash Provided by (Used in) Continuing Operations | The increase (decrease) in cash associated with the entity's continuing operating, investing, and financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label. | View |
| us-gaap | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. | View |
| us-gaap | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. | View |
| us-gaap | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. | View |
| us-gaap | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | View |
| us-gaap | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | View |
| us-gaap | Net Income (Loss) Available to Common Stockholders, Basic | Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. | View |
| us-gaap | Noncash or Part Noncash Acquisition, Other Liabilities Assumed | Amount of liabilities, classified as other, assumed in acquiring a business or in consideration for an asset received in a noncash or part noncash acquisition. | View |
| us-gaap | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). | View |
| us-gaap | Notes Payable | Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. | View |
| us-gaap | Notes Payable, Current | Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. | View |
| us-gaap | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. | View |
| us-gaap | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. | View |
| us-gaap | Operating Leases, Future Minimum Payments Due | Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year. | View |
| us-gaap | Operating Leases, Future Minimum Payments Due, Next Twelve Months | Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. | View |
| us-gaap | Operating Leases, Future Minimum Payments, Due in Four Years | Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. | View |
| us-gaap | Operating Leases, Future Minimum Payments, Due in Three Years | Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. | View |
| us-gaap | Operating Leases, Future Minimum Payments, Due in Two and Three Years | Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second and third fiscal years following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. | View |
| us-gaap | Operating Leases, Future Minimum Payments, Due in Two Years | Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. | View |
| us-gaap | Operating Loss Carryforwards | Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. | View |
| us-gaap | Other Assets, Current | Amount of current assets classified as other. | View |
| us-gaap | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. | View |
| us-gaap | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax | Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss). | View |
| us-gaap | Proceeds from (Payments for) Other Financing Activities | Amount of cash inflow (outflow) from financing activities classified as other. | View |
| us-gaap | Other Liabilities, Current | Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. | View |
| us-gaap | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. | View |
| us-gaap | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. | View |
| us-gaap | Other Receivables | Amount due from parties in nontrade transactions, classified as other. | View |
| us-gaap | Payments of Debt Issuance Costs | The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt. | View |
| us-gaap | Payments to Acquire Short-term Investments | The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term. | View |
| us-gaap | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | View |
| us-gaap | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | View |
| us-gaap | Preferred Stock, Shares Issued | Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. | View |
| us-gaap | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | View |
| us-gaap | Preferred Stock, Shares Subscribed but Unissued, Subscriptions Receivable | Amount of subscription receivable from investors who have been allocated nonredeemable preferred stock or preferred stock redeemable solely at the option of the issuer. | View |
| us-gaap | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. | View |
| us-gaap | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. | View |
| us-gaap | Prepaid Insurance | Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer. | View |
| us-gaap | Proceeds from Issuance Initial Public Offering | The cash inflow associated with the amount received from entity's first offering of stock to the public. | View |
| us-gaap | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. | View |
| us-gaap | Proceeds from Issuance of Long-term Debt | The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer. | View |
| us-gaap | Proceeds from Issuance of Preferred Stock and Preference Stock | Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation. | View |
| us-gaap | Proceeds from Issuance of Private Placement | The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. | View |
| us-gaap | Proceeds from Issuance of Redeemable Convertible Preferred Stock | The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder. | View |
| us-gaap | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised. | View |
| us-gaap | Proceeds from Issuance of Warrants | The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). | View |
| us-gaap | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. | View |
| us-gaap | Proceeds from Warrant Exercises | The cash inflow associated with the amount received from holders exercising their stock warrants. | View |
| us-gaap | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. | View |
| us-gaap | Property, Plant and Equipment, Gross | Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. | View |
| us-gaap | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. | View |
| us-gaap | Reclassifications of Temporary to Permanent Equity | The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2. | View |
| us-gaap | Reimbursement Revenue (Deprecated 2018-01-31) | Repayment received or receivable for expenses incurred on behalf of a client or customer, other than those reimbursements received by landlords from tenants. | View |
| us-gaap | Repayments of Notes Payable | The cash outflow for a borrowing supported by a written promise to pay an obligation. | View |
| us-gaap | Research and Development Asset Acquired Other than Through Business Combination, Written-off | The amount of the write-off for research and development assets that were acquired in a transaction other than a business combination. | View |
| us-gaap | Restricted Cash and Cash Equivalents | Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Restricted Cash and Cash Equivalents, Noncurrent | Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Restricted Stock or Unit Expense | Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement. | View |
| us-gaap | Retained Earnings (Accumulated Deficit) | The cumulative amount of the reporting entity's undistributed earnings or deficit. | View |
| us-gaap | Revenue from Grants (Deprecated 2018-01-31) | Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements. | View |
| us-gaap | Revenue from Related Parties | Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates. | View |
| us-gaap | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). | View |
| us-gaap | Sale of Stock, Price Per Share | Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | The risk-free interest rate assumption that is used in valuing an option on its own shares. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | Number of shares authorized for issuance under share-based payment arrangement. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price (Deprecated 2012-01-31) | The weighted average price at which option holders acquired shares when converting their stock options into shares under the plan during the reporting period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | Weighted average price of options that were either forfeited or expired. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | Net number of share options (or share units) granted during the period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Gross number of share options (or share units) granted during the period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (Deprecated 2012-01-31) | The weighted average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on stock options awarded under the plan during the reporting period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | Number of options outstanding, including both vested and non-vested options. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value (Deprecated 2013-01-31) | Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. | View |
| us-gaap | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding | The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | Number of non-vested options outstanding. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | Number of options vested. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value | Weighted average grant-date fair value of options vested. | View |
| us-gaap | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity. | View |
| us-gaap | Stockholders' Equity Note, Stock Split, Conversion Ratio | Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one. | View |
| us-gaap | Stockholders' Equity, Other | This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy. | View |
| us-gaap | Stock Issued | The fair value of stock issued in noncash financing activities. | View |
| us-gaap | Stock Issued During Period, Shares, Acquisitions | Number of shares of stock issued during the period pursuant to acquisitions. | View |
| us-gaap | Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) | Number of shares issued as consideration for cash for development stage entities. | View |
| us-gaap | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | View |
| us-gaap | Stock Issued During Period, Shares, Other | Number of shares of stock issued attributable to transactions classified as other. | View |
| us-gaap | Stock Issued During Period, Shares, Reverse Stock Splits | Reduction in the number of shares during the period as a result of a reverse stock split. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | View |
| us-gaap | Stock Issued During Period, Value, Acquisitions | Value of stock issued pursuant to acquisitions during the period. | View |
| us-gaap | Stock Issued During Period, Value, Conversion of Convertible Securities | The gross value of stock issued during the period upon the conversion of convertible securities. | View |
| us-gaap | Stock Issued During Period, Value, Conversion of Units | Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit). | View |
| us-gaap | Stock Issued During Period, Value, Employee Stock Purchase Plan | Aggregate change in value for stock issued during the period as a result of employee stock purchase plan. | View |
| us-gaap | Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) | Value of shares issued as consideration for cash for development stage entities. | View |
| us-gaap | Stock Issued During Period, Value, Issued for Services | Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. | View |
| us-gaap | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. | View |
| us-gaap | Stock Issued During Period, Value, Other | Value of shares of stock issued attributable to transactions classified as other. | View |
| us-gaap | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited. | View |
| us-gaap | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). | View |
| us-gaap | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. | View |
| us-gaap | Stock Repurchased During Period, Value | Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. | View |
| us-gaap | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) | Amount of a stock repurchase plan authorized by an entity's Board of Directors. | View |
| us-gaap | Stock Repurchase Program, Remaining Authorized Repurchase Amount | Amount remaining of a stock repurchase plan authorized. | View |
| us-gaap | Unamortized Debt Issuance Expense | The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset. | View |
| us-gaap | Unamortized Loss Reacquired Debt, Noncurrent | Unamortized Loss on Reacquired Debt is the loss incurred upon reacquisition or refinancing of debt, is treated as a deferred charge and amortized over the life of the new debt issued. | View |
| us-gaap | Unrecognized Tax Benefits | Amount of unrecognized tax benefits. | View |
| us-gaap | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns. | View |
| us-gaap | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return. | View |
| us-gaap | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns. | View |
| us-gaap | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations | Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations. | View |
| us-gaap | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Basic and Diluted | Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). | View |
| us-gaap | Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation | Number of shares of common stock subject to repurchase or cancellation determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period. Common stock subject to repurchase are outstanding common shares that are contingently returnable (that is, subject to recall). | View |
Chart of Accounts => Accounts
| Name | View |
|---|---|
| Accumulated Other Comprehensive Income (Loss), Net of Tax | View |
| Additional Paid in Capital, Common Stock | View |
| Class of Warrant or Right, Outstanding | View |
| Common Stock, Capital Shares Reserved for Future Issuance | View |
| Common Stock, Par or Stated Value Per Share | View |
| Debt Conversion, Converted Instrument, Amount | View |
| Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Bonuses | View |
| Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | View |
| Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | View |
| Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | View |
| Effective Income Tax Rate Reconciliation, Tax Credit, Percent | View |
| Effect of Exchange Rate on Cash and Cash Equivalents | View |
| Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations | View |
| Increase (Decrease) in Prepaid Expense and Other Assets | View |
| License and Services Revenue (Deprecated 2018-01-31) | View |
| Licenses Revenue (Deprecated 2018-01-31) | View |
| Long-Term Debt, Maturity, Year One | View |
| Long-Term Debt, Maturity, Year Four | View |
| Long-Term Debt, Maturity, Year Three | View |
| Long-Term Debt, Maturity, Year Two | View |
| Proceeds from Issuance of Preferred Stock and Preference Stock | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period, Weighted Average Grant Date Fair Value (Deprecated 2012-01-31) | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value (Deprecated 2013-01-31) | View |
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | View |
| Stock Issued During Period, Value, Other | View |
| Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | View |
| Accounts Payable, Current | View |
| Accounts Receivable, after Allowance for Credit Loss, Current | View |
| Accrued Liabilities, Current | View |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | View |
| Adjustment of Warrants Granted for Services | View |
| Share-based Payment Arrangement, Decrease for Tax Withholding Obligation | View |
| Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature | View |
| Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings | View |
| APIC, Share-based Payment Arrangement, Recognition and Exercise | View |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | View |
| Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | View |
| Adjustments to Additional Paid in Capital, Warrant Issued | View |
| Share-based Payment Arrangement, Expense | View |
| Amortization of Debt Discount (Premium) | View |
| Amortization of Debt Issuance Costs | View |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | View |
| Area of Real Estate Property | View |
| Assets | View |
| Assets, Current | View |
| Auction Market Preferred Securities, Stock Series, Shares Authorized | View |
| Cash and Cash Equivalents, at Carrying Value | View |
| Cash and Cash Equivalents, Period Increase (Decrease) | View |
| Cash, Cash Equivalents, and Short-term Investments | View |
| Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) | View |
| Class of Warrant or Right, Exercise Price of Warrants or Rights | View |
| Class of Warrant or Right, Number of Securities Called by Each Warrant or Right | View |
| Class of Warrant or Right, Number of Securities Called by Warrants or Rights | View |
| Common Stock, Shares Authorized | View |
| Common Stock, Shares, Issued | View |
| Common Stock, Shares, Outstanding | View |
| Common Stock, Value, Issued | View |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | View |
| Current Income Tax Expense (Benefit) | View |
| Current State and Local Tax Expense (Benefit) | View |
| Debt Conversion, Original Debt, Amount | View |
| Debt Instrument, Interest Rate, Stated Percentage | View |
| Debt Instrument, Unamortized Discount | View |
| Debt Issuance Cost (Deprecated 2016-01-31) | View |
| Deferred Federal Income Tax Expense (Benefit) | View |
| Deferred Income Tax Expense (Benefit) | View |
| Deferred Revenue, Current | View |
| Deferred Revenue, Noncurrent | View |
| Deferred State and Local Income Tax Expense (Benefit) | View |
| Deferred Tax Assets, Goodwill and Intangible Assets | View |
| Deferred Tax Assets, Gross | View |
| Deferred Tax Assets, Operating Loss Carryforwards | View |
| Deferred Tax Assets, Other | View |
| Deferred Tax Assets, Tax Credit Carryforwards | View |
| Deferred Tax Assets, Tax Credit Carryforwards, Research | View |
| Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | View |
| Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | View |
| Deferred Tax Assets, Valuation Allowance | View |
| Defined Benefit Plan, Plan Assets, Contributions by Employer | View |
| Depreciation | View |
| Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | View |
| Dividends, Preferred Stock | View |
| Due to Related Parties | View |
| Earnings Per Share, Basic and Diluted | View |
| Effective Income Tax Rate Reconciliation, Percent | View |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | View |
| Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | View |
| Effective Income Tax Rate Reconciliation, Deduction, Dividend, Percent | View |
| Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | View |
| Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | View |
| Employee-related Liabilities, Current | View |
| Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | View |
| Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | View |
| Equity Issuance, Amount Per Share (Deprecated 2012-01-31) | View |
| Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) | View |
| Equity Method Investment, Aggregate Cost | View |
| Excess Tax Benefit from Share-based Compensation, Operating Activities | View |
| Fair Value Adjustment of Warrants | View |
| Fair Value Inputs, Discount Rate (Deprecated 2018-01-31) | View |
| Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) | View |
| Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases | View |
| Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | View |
| Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss) | View |
| Gain (Loss) on Sale of Investments | View |
| General and Administrative Expense | View |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | View |
| Increase (Decrease) in Accounts Payable | View |
| Increase (Decrease) in Accounts Receivable | View |
| Increase (Decrease) in Accrued Liabilities | View |
| Increase (Decrease) in Deferred Revenue | View |
| Increase (Decrease) in Employee Related Liabilities | View |
| Increase (Decrease) in Operating Assets | View |
| Increase (Decrease) in Restricted Cash | View |
| Interest and Other Income | View |
| Interest Expense | View |
| Interest Paid, Including Capitalized Interest, Operating and Investing Activities | View |
| Investment Income, Net, Amortization of Discount and Premium | View |
| Investment Owned, at Cost | View |
| Investment Owned, at Fair Value | View |
| Investment Owned, Unrecognized Unrealized Appreciation (Depreciation), Net | View |
| Issuance of Stock and Warrants for Services or Claims | View |
| Operating Leases, Rent Expense | View |
| Liabilities | View |
| Liabilities and Equity | View |
| Liabilities, Current | View |
| Long-term Debt | View |
| Notes Payable, Noncurrent | View |
| Net Cash Provided by (Used in) Continuing Operations | View |
| Net Cash Provided by (Used in) Financing Activities | View |
| Net Cash Provided by (Used in) Financing Activities, Continuing Operations | View |
| Net Cash Provided by (Used in) Investing Activities | View |
| Net Cash Provided by (Used in) Investing Activities, Continuing Operations | View |
| Net Cash Provided by (Used in) Operating Activities | View |
| Net Cash Provided by (Used in) Operating Activities, Continuing Operations | View |
| Net Income (Loss) Attributable to Parent | View |
| Net Income (Loss) Available to Common Stockholders, Basic | View |
| Noncash or Part Noncash Acquisition, Other Liabilities Assumed | View |
| Nonoperating Income (Expense) | View |
| Notes Payable | View |
| Notes Payable, Current | View |
| Operating Expenses | View |
| Operating Income (Loss) | View |
| Operating Leases, Future Minimum Payments Due | View |
| Operating Leases, Future Minimum Payments Due, Next Twelve Months | View |
| Operating Leases, Future Minimum Payments, Due in Four Years | View |
| Operating Leases, Future Minimum Payments, Due in Three Years | View |
| Operating Leases, Future Minimum Payments, Due in Two and Three Years | View |
| Operating Leases, Future Minimum Payments, Due in Two Years | View |
| Operating Loss Carryforwards | View |
| Other Assets, Current | View |
| Other Assets, Noncurrent | View |
| Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax | View |
| OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | View |
| Other Liabilities, Current | View |
| Other Liabilities, Noncurrent | View |
| Other Nonoperating Income (Expense) | View |
| Other Receivables | View |
| Other Significant Noncash Transaction, Value of Consideration Given | View |
| Payments of Debt Issuance Costs | View |
| Payments to Acquire Property, Plant, and Equipment | View |
| Payments to Acquire Short-term Investments | View |
| Preferred Stock, Par or Stated Value Per Share | View |
| Preferred Stock, Shares Authorized | View |
| Preferred Stock, Shares Issued | View |
| Preferred Stock, Shares Outstanding | View |
| Preferred Stock, Shares Subscribed but Unissued, Subscriptions Receivable | View |
| Preferred Stock, Value, Issued | View |
| Prepaid Expense and Other Assets, Current | View |
| Prepaid Insurance | View |
| Proceeds from Issuance Initial Public Offering | View |
| Proceeds from Issuance of Common Stock | View |
| Proceeds from Issuance of Long-term Debt | View |
| Proceeds from Issuance of Private Placement | View |
| Proceeds from Issuance of Redeemable Convertible Preferred Stock | View |
| Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | View |
| Proceeds from Issuance of Warrants | View |
| Proceeds from Issuance or Sale of Equity | View |
| Proceeds from Other Equity | View |
| Proceeds from (Payments for) Other Financing Activities | View |
| Proceeds from Sale of Property, Plant, and Equipment | View |
| Proceeds from Sale of Short-term Investments | View |
| Proceeds from Stock Options Exercised | View |
| Proceeds from Warrant Exercises | View |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | View |
| Property, Plant and Equipment, Gross | View |
| Property, Plant and Equipment, Net | View |
| Reclassifications of Temporary to Permanent Equity | View |
| Reimbursement Revenue (Deprecated 2018-01-31) | View |
| Repayments of Notes Payable | View |
| Research and Development Asset Acquired Other than Through Business Combination, Written-off | View |
| Research and Development Expense | View |
| Restricted Cash and Cash Equivalents | View |
| Restricted Cash and Cash Equivalents, Noncurrent | View |
| Restricted Stock or Unit Expense | View |
| Retained Earnings (Accumulated Deficit) | View |
| Revenue from Grants (Deprecated 2018-01-31) | View |
| Revenue from Related Parties | View |
| Revenues | View |
| Sale of Stock, Price Per Share | View |
| Sales Revenue, Services, Other (Deprecated 2018-01-31) | View |
| Share-based Payment Arrangement, Noncash Expense | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price (Deprecated 2012-01-31) | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | View |
| Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) | View |
| Stock Issued During Period, Value, Issued for Services | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (Deprecated 2012-01-31) | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | View |
| Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable | View |
| Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent | View |
| Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price | View |
| Share Price | View |
| Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation | View |
| Short-term Investments | View |
| Square Footage of Real Estate Property (Deprecated 2012-01-31) | View |
| Stockholders' Equity Attributable to Parent | View |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | View |
| Stockholders' Equity Note, Stock Split, Conversion Ratio | View |
| Stockholders' Equity, Other | View |
| Stock Issued | View |
| Stock Issued During Period, Shares, Acquisitions | View |
| Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) | View |
| Stock Issued During Period, Shares, New Issues | View |
| Stock Issued During Period, Shares, Other | View |
| Stock Issued During Period, Shares, Reverse Stock Splits | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | View |
| Stock Issued During Period, Value, Acquisitions | View |
| Stock Issued During Period, Value, Conversion of Convertible Securities | View |
| Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments | View |
| Stock Issued During Period, Value, Conversion of Units | View |
| Stock Issued During Period, Value, Employee Stock Purchase Plan | View |
| Stock Issued During Period, Value, New Issues | View |
| Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | View |
| Stock Issued During Period, Value, Stock Options Exercised | View |
| Stock Repurchased During Period, Value | View |
| Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) | View |
| Stock Repurchase Program, Remaining Authorized Repurchase Amount | View |
| Unamortized Debt Issuance Expense | View |
| Unamortized Loss Reacquired Debt, Noncurrent | View |
| Unrecognized Tax Benefits | View |
| Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | View |
| Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | View |
| Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | View |
| Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations | View |
| Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | View |
| Weighted Average Number of Shares Outstanding, Diluted | View |
| Weighted Average Number of Shares Outstanding, Basic and Diluted | View |
| Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation | View |
| Weighted Average Number of Shares Issued, Basic | View |
| Weighted Average Number of Shares Outstanding, Basic | View |